4//SEC Filing
DiFabio Andrea 4
Accession 0001193125-26-009232
CIK 0001582313other
Filed
Jan 8, 7:00 PM ET
Accepted
Jan 9, 6:52 PM ET
Size
7.5 KB
Accession
0001193125-26-009232
Insider Transaction Report
Form 4
DiFabio Andrea
Chief Legal Officer
Transactions
- Award
Share Option (Right to Buy)
2026-01-09+80,000→ 80,000 totalExercise: $42.15Exp: 2036-01-08→ Common Shares (80,000 underlying) - Award
Restricted Share Units
2026-01-09+15,000→ 15,000 totalExercise: $0.00→ Common Shares (15,000 underlying)
Footnotes (2)
- [F1]Vesting 25% on January 9, 2027, and 75% vesting thereafter over the course of the next 3 years, in equal amounts, on the last day of each month.
- [F2]Each restricted share unit represents a contingent right to receive one Common Share vesting 25% on each of the first four anniversaries of the date of grant, beginning on January 9, 2027.
Documents
Issuer
Xenon Pharmaceuticals Inc.
CIK 0001582313
Entity typeother
Related Parties
1- filerCIK 0001692506
Filing Metadata
- Form type
- 4
- Filed
- Jan 8, 7:00 PM ET
- Accepted
- Jan 9, 6:52 PM ET
- Size
- 7.5 KB